Status:
COMPLETED
Risks of COVID19 in the Pregnant Population
Lead Sponsor:
Mayo Clinic
Conditions:
COVID19
Eligibility:
FEMALE
18-45 years
Brief Summary
It is unclear how COVID19 can be passed from mother to infant. The study investigators aim to collect maternal and neonatal samples from COVID19-infected pregnant women and compare them to pregnant wo...
Detailed Description
The objectives are to understand the prevalence of maternal fetal transmission, risk factors and outcomes of a COVID19 positive pregnancy, and how the virus can be passed from mother to infant in the ...
Eligibility Criteria
Inclusion
- Pregnant women ages 18 - 45 years of age and their newborn infants
- Willing and able to provide written informed consent
- Planning to deliver at Mayo Clinic in Rochester, MN
Exclusion
- Positive for HIV, HBV, or TB
- Delivery does not occur at Mayo Clinic
Key Trial Info
Start Date :
May 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT04379284
Start Date
May 8 2020
End Date
October 1 2021
Last Update
October 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Rochester
Rochester, Minnesota, United States, 55905